|
|
Real-World Analytics Summit 2017
Boston, Massachusetts, USA 19-21 September 2017
|
Description:
The 5th annual Real-World Analytics meeting (formerly known as Advanced Pharma Analytics Summit) supports drug developers to effectively leverage RWE and analytics and pursue more evidence-based commercial decision-making.
Learn how pharma and biotech companies are using these tools in order to both optimize health economics, market access, pricing and reimbursement strategies, and create value-generating opportunities for stakeholders.
Join the Real-World Analytics expert community in this case study led discussion and discover how to better answer pressing questions in the post-market stages of drug development.
URLs:
Brochure: https://go.evvnt.com/133322-1
Booking: https://go.evvnt.com/133322-2
Time: 08:00 to 17:00
Price:
Earlybird Pharma: USD 2299,
Standard Pharma: USD 2699,
Earlybird Solution Provider: USD 3579,
Standard Solution Provider: USD 3779
Speakers: Frank Zhang Alnylam Pharmaceuticals, Julie Locklear EMD Serono, Sandy Balkin Sanofi US, Kitty Rajagopalan Sunovion Pharmaceuticals, James Harnett Pfizer
Back